(Q46087859)
Statements
1 reference
Intravitreal injection of 2.5 mg versus 1.25 mg bevacizumab (Avastin) for treatment of CNV associated with AMD. (English)
1 reference
Khalil Ghasemi Falavarjani
1 reference
Aminollah Nikeghbali
1 reference
Mehdi Modarres
1 reference
Masood Naseripour
1 reference
Masih Hashemi
1 reference
Mohammad Mehdi Parvaresh
1 reference
1 March 2009
1 reference
1 reference
29
1 reference
3
1 reference
319-324
1 reference